Breast Radiotherapy: Considerations in Older Patients

Clinical Oncology

Volumn 21, Issue 2, 2009, Pages 111-117

  Kunkler, I H ^a   Williams, L J ^b   King, C C ^b   Jack, W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Breast cancer; radiotherapy

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; EXEMESTANE; TAMOXIFEN;

ADJUVANT THERAPY; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; ELDERLY CARE; HUMAN; MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; RADIOTHERAPY, ADJUVANT;

EID: 59149105921     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.11.012     Document Type: Article

References (67)

1. Althuis M.D., Dozier J.M., Anderson W.F., et al. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34 (2005) 405-412
2. NCIDCCPS, Surveillance, Epidemiology, and End Results (SEER) program. Available from: www.seer.cancer.gov. SEER stat database: incidence - SEER 9 Regs Public Use Nov 2004 Sub (1973-2002). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. released April 2005.
3. Scottish Executive. Cancer scenarios: an aid to planning cancer services in Scotland in the next decade (2001), Scottish Executive, Edinburgh
4. Barton M., and Delaney G. Radiotherapy in cancer care: estimating optimal utilisation from a review of evidence based guidelines. Available from:. http://www.ncci.org.au/pdf/radiotherapyreport.pdf
5. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in extent of surgery for early breast cancer on local recurrence and 15- year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
6. Hutchins L.F., Unger J.M., Crowley J.J., et al. Underrepresentation of patients 65 years or older in cancer treatment trials. N Engl J Med 341 (1999) 2061-2067
7. Yee K.W.L., Pater J.L., Pho L., et al. Enrolment of older patients in cancer treatment trials in Canada: why is age a barrier?. J Clin Oncol 21 (2003) 1618-1623
8. Wildiers H., Kunkler I., and Biganzoli L. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8 (2007) 1101-1115
9. Huguenin P., Glanzmann C., and Lutolf L.M. Acute toxicity of curative radiotherapy in elderly patients. Strahlenther Onkol 172 (1996) 658-663
10. Wyckoff J., Greenberg H., Sanderson R., et al. Breast irradiation in the older women: a toxicity study. J Am Geriatr Soc 42 (1994) 150-152
11. Chu J., Diehr P., Fiegl P., et al. The effect of age on the care of women with breast cancer in community hospitals. J Gerontol 42 (1987) 185-190
12. Greenfield S., Blanco D.M., Elashoff R.M., et al. Patterns of care related to age of breast cancer patients. JAMA 257 (1987) 2766-2770
13. Silliman R.A., Guadagnol E., Weitberg A.B., et al. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44 (1989) M46-M60
14. Athas W.F., Adams-Cameron M., Hunt W.C., et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92 (2000) 269-271
15. Louwman W.J., Janssen-Heijnen M.L., Houterman S., et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population based study. Eur J Cancer 41 (2005) 779-785
16. Ballard-Barbash R., Potosky A.L., Harlan L.C., et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88 (1996) 716-726
17. Satariano W.A., and Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120 (1994) 104-110
18. Hershman D.L., Buono D., McBride R.B., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 100 (2008) 199-206
19. Lavelle K., Moran A., Howell A., et al. Older women with operable breast cancer are less likely to have surgery. Br J Surg 10 (2007) 1209-1215
20. Vinh-Hung V., and Verschraegen C. Breast conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence: survival impact and time trends. J Natl Cancer Inst 96 (2004) 115-121
21. Tai P., Cserni G., Van de Steene J., et al. Modelling the effect of age in T1-2 breast cancer using the SEER database. BMC Cancer 5 (2005) 130
22. Whelan T., Clark R., Roberts R., et al. Ipsilateral breast tumor recurrence from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 30 (1994) 11-16
23. Fisher E.R., Anderson S., Tan-Chiu E., et al. Fifteen-year prognostic discriminants for invasive breast carcinoma. National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 91 (2001) 1679-1687
24. Yood M.U., Owusu C., and Buist D.S. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206 (2008) 66-75
25. Truong P.T., Bernstein V., Lesperance M., et al. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191 (2006) 749-755
26. Siesling S., van de Poll-Franse L.V., Jobsen J.J., et al. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001. Breast 16 (2007) 606-614
27. Nold R.J., Beamer R.L., Helmer S.D., et al. Factors influencing a woman's choice to undergo breast conserving surgery vs modified radical mastectomy. Am J Surg 180 (2000) 413-418
28. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in south Netherlands, 1995 to 2002. Cancer 106 (2006) 2734-2742
29. Veronesi U., Luini A., Delvecchio M., et al. Radiotherapy after breast conserving surgery in women with localised cancer of the breast. N Engl J Med 328 (1993) 1587-1591
30. The Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Natl Cancer Inst 82 (1990) 277-282
31. Liljegren G., Holmberg L., Bergh J., et al. 10-year results after sector resection with or without postoperative radiotherapy for stage 1 breast cancer - 5 year results of a randomized trial. J Natl Cancer Inst 86 (1994) 717-722
32. Mannino M., and Yarnold J.R. Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?. Radiother Oncol (2008) doi:10.1016/j. radonc.2008,05.002
33. Hughes K.S., Schnapper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years or older with early breast cancer. N Engl J Med 351 (2004) 971-977
34. Kunkler I.H. PRIME II breast cancer trial. Clin Oncol 16 (2004) 447-448
35. Coombes R.C., Kilburn L.S., Snowdon C.F., et al. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 369 (2007) 559-570
36. Howell A., Cuzick J., Baum M., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
37. Scalliet P.G., and Kirkove C. Breast cancer in elderly women: can radiotherapy be omitted. Eur J Cancer 43 (2007) 2264-2269
38. Nuyten D.S., Kreike B., Hart A.A., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8 (2006) R62
39. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional irradiation. N Engl J Med 345 (2001) 1378-1387
40. Whelan T., McKenzie R., Julian J., et al. Randomized trial of breast cancer irradiation schedules after lumpectomy for women with lymph node negative breast cancer. J Natl Cancer Inst 94 (1994) 1143-1150
41. Group TST. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 (2008) 1098-1107
42. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
43. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose rate brachytherapy alone after lumpectomy in patients with early stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 50 (2001) 1003-1011
44. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
45. Ott O.J., Hildebrandt G., Potter R., et al. Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Result of the German-Austrian multi-centre trial. Radiother Oncol 82 (2007) 281-286
46. Formenti S.C. External beam partial breast irradiation. Semin Radiat Oncol 15 (2005) 92-99
47. Kozak K.R., Smith B.L., Adams J., et al. Accelerated partial breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66 (2006) 691-698
48. Vaidya J.S., Tobias J.S., and Baum M. Intraoperative radiotherapy for breast cancer. Lancet Oncol 5 (2004) 165-173
49. Orecchia R., Ciocca M., Lazzari R., et al. Intraoperative radiation therapy with electrons (ELIOT) in early stage breast cancer. Breast 138 (2003) 1253-1256
50. Sauer R., Sautter-Bihl M.L., Budach W., et al. Accelerated partial breast irradiation: consensus statement of 3 German oncology societies. Cancer 110 (2007) 1187-1194
51. Whelan T.J., Levine M., Julian J., et al. The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Cancer 88 (2000) 2260-2266
52. Prescott R.P., Kunkler I.H., Williams L.J., et al. A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 11 (2007) 1-149
53. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
54. Sprangers M.A., Groenvold M., Arraras J.I., et al. European Organisation for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three country field study. J Clin Oncol 14 (1996) 2756-2768
55. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
56. Lawton M.P. The Philadelphia Geriatric Cancer Morale Scale. A revision. J Gerontol 30 (1975) 85-89
57. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
58. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
59. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
60. Harris J.R., Halpin-Murphy P., McNeese M., et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44 (1999) 989-990
61. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
62. Eifel P., Axelson J.A., Costa J., et al. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-2, 2000. J Natl Cancer Inst 93 (2001) 979-989
63. Smith B.D., Haffty B.G., Hurria A., et al. Postmastectomy radiation and survival in older women. J Clin Oncol 30 (2008) 4901-4907
64. Lee J.C., Truong F.T., Kader H.A., et al. Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer. Clin Oncol 17 (2005) 623-629
65. Goldhirsch A., Wood W.C., Gelber R.D., et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer. Ann Oncol 18 (2007) 1133-1144
66. Kunkler I.H., Canney P., van Tienhoven G., et al. Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol 20 (2008) 31-34
67. Kyndi M, Overgaard M, Nielsen HM, et al. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol, in press, doi:10.1016/j.radonc.2008.04.014.